No Detail Found!

Candida Awareness: Overview of Characteristics, Resistance to Antifungal Agents, and Biocontrol by Natural Products

Author(s)
Nourah S. Alzahrani Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia ; Biology Department, Faculty of Science, Jazan University, Jazan, Saudi Arabia
Magda M. Aly Biology Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia;Botany and Microbiology Department, Faculty of Science, Kafrelsheikh University, Egypt;Najla Bint Saud Al Saud Center for Excellence Research in Biotechnology, Jeddah, Saudi Arabia
Reda H. Amashah Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia; Biology Department, Faculty of Science, Jazan University, Jazan, Saudi Arabia
Abstract
Candida species have long been recognized as harmless commensals associated with humans. These organisms are typically located on the mucosal surfaces of the gastrointestinal and genitourinary tracts, as well as on human skin. Nonetheless, they can act as opportunistic pathogens in patients with weakened immune systems and those who are immunocompromised. The increase in morbidity and mortality associated with Candida is reported to be alarming on a global scale (Nosocomial infections), primarily because Candida is the primary cause of hospital-acquired infections. Over the past few years, there has been a tremendous gain in our understanding of the mechanisms and components that contribute to infections. Furthermore, new virulence mechanisms have been identified recently. In conclusion, this review provide an update on the understanding of the pathogenic mechanisms of this important human pathogen and explore the use of natural products as antifungal agents.
Publication Details
Page(s) 405-417
Published Journal: Pakistan Journal of Life and Social Sciences, Volume: 23, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
Candida Awareness Antifungal Agents Biocontrol Natural Products
References
Alzahrani N. Amashah R,Kameli N Aly M R .2024 .Significant Antifungal Activity of Streptomyce plicatus NM3 Against Clinically Relevant Candida Species Collected from Jazan Hospital. Journal of Contemporary Medical Sciences, 6 : 467-474.
Arendrup M. C. .2013 .Candida and candidaemia. Susceptibility and epidemiology. Dan Med, 60(11) : B4698.
Arendrup M. C.,Bruun B.,Christensen J. J.,Fuursted K.,Johansen H. K.,Kjaeldgaard P.,Truberg K. .2011 .National surveillance of fungemia in Denmark (2004 to 2009). Journal of clinical microbiology, 49(1) : 325-334.
Arendrup M. C.,Garcia-Effron G.,Lopez C.,Rodriguez-Tudela A. G.,Cuenca-Estrella J. L.,Perlin M.,D. S. M. .2010 .Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media. Antimicrobial agents and chemotherapy, 54(1) : 426-439.
Arendrup M. C.,Patterson T. F. .2017 .Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. The Journal of infectious diseases, 216(suppl) : S445-S451.
Arjuna N. B.,Morrison Christine J. .2005 .Laboratory diagnosis of invasive candidiasis. Journal of microbiology, 43(spc1) : 65-84.
Aydemir ,Demiray T.,Aydemir M.,Altındiş Y.,M. Y. .2017 .Emerge of non -albicans Candida species; evaluation of Candida species and antifungal susceptibilities according to years. Biomedical Research (0970-938X), 28(6) : .
Barousse M. M.,Van Der Pol B. J.,Fortenberry D.,Orr D.,Fidel P. L. .2004 .Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents. Sexually transmitted infections, 80(1) : 48-53.
Belghit S.,Driche E. H.,Bijani C.,Zitouni A.,Sabaou N.,Badji B.,Mathieu F. .2016 .Activity of 2, 4-Di-tert-butylphenol produced by a strain of Streptomyces mutabilis isolated from a Saharan soil against Candida albicans and other pathogenic fungi. Journal de mycologie medicale, 26(2) : 160-169.
Blot S.,Vandijck D.,Vandewoude K. .2008 .Risk factors for Candida non-albicans candidemia. Diagnostic Microbiology & Infectious Disease, 3(61) : 362-363.
Brown A. J. P. .2002 .Expression of growth form-specific factors during morphogenesis in Candida albicans. Candida and candidiasis, 87 : 93.
Brown ,Denning D. W.,Gow N. A.,Levitz S. M.,Netea M. G.,White T. C. .2012 .Hidden killers: human fungal infections. Science translational medicine, 4(165) : 165rv13-165rv13.
Calvo B.,Melo A. S.,Perozo-Mena A.,Hernandez M.,Francisco E. C.,Hagen F.,Colombo A. L. .2016 .First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. Journal of Infection, 73(4) : 369-374.
Carmo A.,Rocha M.,Pereirinha P.,Tomé R.,Costa E. .2023 .Antifungals: From pharmacokinetics to clinical practice. Antibiotics, 12(5) : 884.
Carrillo-Muñoz A. J.,Giusiano G.,Cárdenes D.,Hernández-Molina J. M.,Eraso E.,Quindós G.,Guarro J. .2008 .Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis. International journal of antimicrobial agents, 31(6) : 540-543.
Cateau E.,Rodier M. H.,Imbert C. .2012 .Could antifungal lock be useful in the management of candidiasis linked with catheters? Medecine Sciences: M/S,. , 28(8-9) : 740-745.
Chowdhary A.,Sharma C.,Duggal S.,Agarwal K.,Prakash A.,Singh P. K.,Meis J. F. .2013 .new clonal strain of Candida auris. , 19(10) : 1670.
Costa-de-Oliveira S.,Marcos Miranda,Silva I.,R. M. I.,Rocha A.,Amorim R.,PinaVaz A.,C. A. .2011 .FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy. Antimicrobial agents and chemotherapy, 55(3) : 1312-1314.
Dabas P. S. .2013 .An approach to etiology, diagnosis and management of different types of candidiasis. Journal of Yeast and Fungal Research, 4(6) : 63-74.
Dadar M.,Tiwari R.,Karthik K.,Chakraborty S.,Shahali Y.,Dhama K. .2018 .Candida albicansBiology, molecular characterization, pathogenicity, and advances in diagnosis and controlAn update. Microbial pathogenesis, 117 : 128-138.
Davicino R.,Mattar M.A.,Casali Y.A.,Graciela S.,Micalizzi B. .2007 .Antifungal activity of plant extracts used in folk medicine in Argentina. Revista Peruana de Biología, 14 : 247-251.
Denning D. W. .2022 .Antifungal drug resistance: an update. European Journal of Hospital Pharmacy, 29(2) : 109-112.
Diekema D. J.,Messer S. A.,Hollis R. J.,Jones R. N.,Pfaller M. A. .2003 .Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. Journal of clinical microbiology, 41(8) : 3623-3626.
Douglas L. J. .2003 .Candida biofilms and their role in infection. , 11(1) : 30-36.
Efimova S. S.,Schagina L. V.,Ostroumova O. S. .2014 .Investigation of channel-forming activity of polyene macrolide antibiotics in planar lipid bilayers in the presence of dipole modifiers. Acta Naturae (англоязычная версия), 6(23) : 67-79.
Eggimann P.,Que Y. A.,Revelly J. P.,Pagani J. L. .2015 .Preventing invasive candida infections. Where could we do better?. Journal of Hospital Infection, 89(4) : 302-308.
Zakhem El,Istambouli A. E.,Alkozah R.,Gharamti M.,Tfaily A.,Jabbour M. A.,Kanj J. F.,S. S. J. F. .2021 .Predominance of Candida glabrata among non-albicans Candida species in a 16-year study of candidemia at a tertiary care center in Lebanon. , 10(1) : 82.
Jr Fidel,Vazquez P. L.,Sobel J. A.,J. D. J. A. .1999 .Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clinical microbiology reviews, 12(1) : 80-96.
Fisher J. F.,Sobel J. D.,Kauffman C. A.,Newman C. A. .2011 .Candida urinary tract infections treatment. Clinical infectious diseases, 52(suppl) : S457-S466.
Fisher M. C.,Alastruey-Izquierdo A.,Berman J.,Bicanic T.,Bignell E. M.,Bowyer P.,Verweij P. E. .2022 .Tackling the emerging threat of antifungal resistance to human health. Nature reviews microbiology, 20(9) : 557-571.
Fitzpatrick D. A.,Logue M. E.,Stajich J. E.,Butler G. .2006 .A fungal phylogeny based on 42 complete genomes derived from supertree and combined gene analysis. BMC evolutionary biology, 6, : 1-15.
Garcia-Effron G.,Katiyar S. K.,Park S.,Edlind T. D.,Perlin D. S. .2008 .A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrobial agents and chemotherapy, 52(7) : 2305-2312.
Guessous-Idrissi N.,Essari A.,Abdallaoui M. S.,Youssouf M. .2007 .Première identification de Candida dubliniensis au centre hospitalier universitaire Ibn Rochd de Casablanca (Maroc). Journal de Mycologie Médicale, 17(2) : 77-81.
Hameed R. H.,Mohammed G. J.,Hameed I. H. .2018 .Matricaria chamonbmilla: Bioactive compounds of methanolic fruit extract using GC-MS and FTIR techniques and determination of its antimicrobial properties. Indian J Public Health Res Dev, 9(3) : 223-8.
Hesstvedt L.,Gaustad P.,Andersen C. T.,Haarr E.,Hannula R.,Haukland H. H.,Åsheim S. .2015 .Twenty-two years of candidaemia surveillance: results from a Norwegian national study. Clinical Microbiology and Infection, 21(10) : 938-945.
Hou J.,Qu P.,Fu H.,Wang P.,Wang Y.,Zhu Z.,W. Z. .2012 .Gilvocarcin HE: a new polyketide glycoside from Streptomyces sp. The Journal of antibiotics, 65(10) : 523-526.
Houšť J.,Spížek J.,Havlíček V.,Metabolites V. .2020 .Antifungal drugs. MDPI AG, 10 : .
Jakubiec-Krzesniak K.,Rajnisz-Mateusiak A.,Guspiel A.,Ziemska J.,Solecka J. .2018 .Secondary metabolites of actinomycetes and their antibacterial, antifungal and antiviral properties. Polish journal of microbiology, 67(3) : 259.
Jeffery-Smith A.,Taori S. K.,Schelenz S.,Jeffery K.,Johnson E. M.,Borman A.,Brown C. S. .2018 .Candida auris: a review of the literature. Clinical microbiology reviews, 31(1) : 10-1128.
Kainz K.,Bauer M. A.,Madeo F.,Carmona-Gutierrez D. .2020 .Fungal infections in humans: the silent crisis. Microbial Cell, 7(6) : 143.
Kamath P.,Pais M.,Nayak M. G. .2013 .Risk of vaginal candidiasis among pregnant women. Int J Curr Microbiol Appl Sci, 2 : 141-146.
Kofla G.,Ruhnke M. .2011 .Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis-review of the literature. European journal of medical research, 16(4) : 159.
Kojic E. M.,Darouiche R. O. .2004 .Candida infections of medical devices. Clinical microbiology reviews, 17(2) : 255-267.
Kuhbacher A.,Burger-Kentischer A.,Rupp S. .2017 .Interaction of Candida species with the skin. Microorganisms, 5(2) : 32.
Kumamoto C. A.,Vinces M. D. .2005 .Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cellular microbiology, 7(11) : 1546-1554.
Lagane C. .2007 .Implication de PPAR-gamma (Doctoral dissertation. , : .
Li W. R.,Shi Q. S.,Dai H. Q.,Liang Q.,Xie X. B.,Huang X. M.,Zhang L. X. .2016 .Antifungal activity, kinetics and molecular mechanism of action of garlic oil against Candida albicans. Scientific reports, 6(1) : 22805.
Lockhart S. R.,Etienne K. A.,Vallabhaneni S.,Farooqi J.,Chowdhary A.,Govender N. P.,Litvintseva A. P. .2017 .Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clinical Infectious Diseases, 64(2) : 134-140.
Maertens J. A. .2004 .History of the development of azole derivatives. Clinical Microbiology and Infection, 10 : 1-10.
Mahmoud D. A.,Hassanein N. M.,Youssef K. A.,Abou Zeid M. A. .2011 .Antifungal activity of different neem leaf extracts and the nimonol against some important human pathogens. Brazilian Journal of Microbiology, 42 : 1007-1016.
Miceli M. H.,Díaz J. A.,Lee S. A. .2011 .Emerging opportunistic yeast infections. The Lancet infectious diseases, 11(2) : 142-151.
Miranda L. N.,Van Der Heijden I. M.,Costa S. F.,Sousa A. P. I.,Sienra R. A.,Gobara S.,Levin A. S. .2009 .Candida colonisation as a source for candidaemia. Journal of Hospital Infection, 72(1) : 9-16.
Murugesh J.,Annigeri R. G.,Mangala G. K.,Mythily P. H.,Chandrakala J. .2019 .Evaluation of the antifungal efficacy of different concentrations of Curcuma longa on Candida albicans: An: in vitro: study. Journal of Oral and Maxillofacial Pathology, 23(2) : 305.
Naglik J. R.,Challacombe S. J.,Hube B. .2003 .Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiology and molecular biology reviews, 67(3) : 400-428.
Nash A. K.,Auchtung T. A.,Wong M. C.,Smith D. P.,Gesell J. R.,Ross M. C.,Petrosino J. F. .2017 .The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome, 5 : 1-13.
Nett J. E.,Crawford K.,Marchillo K.,Andes D. R. .2010 .Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrobial agents and chemotherapy, 54(8) : 3505-3508.
Nucci M.,Anaissie E. .2001 .Revisiting the source of candidemia: skin or gut? Clinical infectious diseases. , 33(12) : 1959-1967.
Odds F. C. .1988 .Ecology of Candida and epidemiology of candidosis. Candida and candidosis. , : .
Oh D. C.,Poulsen M.,Currie C. R.,Clardy J. .2011 .Sceliphrolactam, a polyene macrocyclic lactam from a wasp-associated Streptomyces sp. Organic letters, 13(4) : 752-755.
Pammi M.,Butler L.,Gacser G.,Bliss A.,J. M. A. .2013 .Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis. The Pediatric infectious disease journal, 32(5) : e206-e216.
Pappas P. G.,Kauffman C. A.,Andes D. R.,Clancy C. J.,Marr K. A.,Ostrosky-Zeichner L.,Sobel J. D. .2016 .Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clinical infectious diseases, 62(4) : e1-e50.
Pappas P. G.,Kauffman C. A.,Andes D.,Jr Benjamin,Calandra D. K.,Edwards T. F.,Jr T. F.,Sobel J. E.,J. D. J. E. .2009 .Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clinical infectious diseases: an official publication of the Infectious Diseases Society. , 48(5) : 503.
Perlin D. S.,Moţ M.,C. A. M. .2011 .Current perspectives on echinocandin class drugs. Future microbiology, 6(4) : 441-457.
Pfaller M. A.,Diekema D. .2007 .Epidemiology of invasive candidiasis: a persistent public health problem. Clinical microbiology reviews, 20(1) : 133-163.
Pfaller M. A.,Diekema D. J.,Jones R. N.,Sader H. S.,Fluit A. C.,Hollis R. J. .2001 .International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. Journal of Clinical Microbiology, 39(9) : 3254-3259.
Rathod B. B.,Korasapati R.,Sripadi P.,P. P. .2018 .Novel actinomycin group compound from newly isolated Streptomyces sp. RAB12: isolation, characterization, and evaluation of antimicrobial potential. Applied Microbiology and Biotechnology, 102 : 1241-1250.
Rifai A.,Endraswari P. D.,Setiawati Y.,Koendhori E. B. .2024 .Effects of Clove Leaf Essential Oil (Syzygium aromaticum) in Inhibiting Biofilm Formation on Candida albicans Isolate. , : .
Rodrigues C. F.,Henriques M. .2017 .Oral mucositis caused by Candida glabrata biofilms: Failure of the concomitant use of fluconazole and ascorbic acid. Therapeutic advances in infectious disease, 4(1) : 10-17.
Saadabi AMA .2006 .Antifungal activity of some Saudi plants used in traditional medicine. Asian J. Plant Sci., 5 : 907-909.
SC D.,Saini S. .2015 .Candidiasis: Past, present and future. Int J Infect Trop Dis, 2(1) : 12-24.
Segal E.,Frenkel M. .2018 .Experimental in vivo models of candidiasis. Journal of fungi, 4(1) : 21.
Seleem D.,Pardi V.,Murata R. M. .2017 .Review of flavonoids: A diverse group of natural compounds with anti-Candida albicans activity in vitro. Archives of oral biology, 76 : 76-83.
Sharma M.,Sharma R. .2011 .Synergistic antifungal activity of Curcuma longa (turmeric) and Zingiber officinale (ginger) essential oils against dermatophyte infections. Journal of essential oil Bearing Plants, 14(1) : 38-47.
Sigei E. C.,Muturi M.,Bii C. .2015 .Antifungal activities of Camellia sinensis crude extract, mixture with milk, on selected pathogenic and mycotoxic fungi. Journal of Medicinal Plants Research, 9(42) : 1070-1080.
Silva S.,Negri M.,Henriques M.,Oliveira R.,Williams D. W.,Azeredo J. .2012 .Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS microbiology reviews, 36(2) : 288-305.
Singh D. K.,Tóth R.,Gácser A. .2020 .Mechanisms of pathogenic Candida species to evade the host complement attack. Frontiers in cellular and infection microbiology, 10 : 94.
Spellberg B.,Ibrahim A. S.,Edwards Jr,Filler J. E.,S. G. J. E. .2005 .Mice with disseminated candidiasis die of progressive sepsis. The Journal of infectious diseases, 192(2) : 336-343.
Srivastava V.,Dubey A. K. .2016 .Anti-biofilm activity of the metabolites of Streptomyces chrestomyceticus strain ADP4 against Candida albicans. Journal of bioscience and bioengineering, 122(4) : 434-440.
Sullivan D.,Coleman D. .1998 .Candida dubliniensis: characteristics and identification. Journal of clinical microbiology, 36(2) : 329-334.
Szymański M.,Chmielewska S.,Czyżewska U.,Malinowska M.,Tylicki A. .2022 .Echinocandinsstructure, mechanism of action and use in antifungal therapy. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1) : 876-894.
Taei M.,Chadeganipour M.,Mohammadi R. .2019 .An alarming rise of non-albicans Candida species and uncommon yeasts in the clinical samples; a combination of various molecular techniques for identification of etiologic agents. BMC research notes, 12 : 1-7.
Talapko J.,Juzbašić M.,Matijević T.,Pustijanac E.,Bekić S.,Kotris I.,Škrlec I. .2021 .Candida albicans-the virulence factors and clinical manifestations of infection. Journal of Fungi, 7(2) : 79.
Thompson III,Patel G. R.,Kirkpatrick P. K.,Westbrook W. R.,Berg S. D.,Erlandsen D.,Patterson J.,T. F. J. .2010 .Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Pathology, Oral Radiology, and Endodontology, 109(4) : 488-495.
Umadevi A.,Kumari C. H. A. M. P. A.,Kumar P. A.,Am H. S.,Divya K.,Hisana P. V. .2018 .Development and evaluation of polyherbal gel for antifungal activity. Int. J. Curr. Pharm. Res, 10(5) : 40-43.
Veen M.,Stahl U.,Lang C. .2003 .Combined overexpression of genes of the ergosterol biosynthetic pathway leads to accumulation of sterols in Saccharomyces cerevisiae. FEMS yeast research, 4(1) : 87-95.
Vermes A.,Guchelaar H. J.,Dankert J. .2000 .Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. Journal of Antimicrobial Chemotherapy, 46(2) : 171-179.
Yaralizadeh M.,Abedi P.,Namjoyan F.,Fatahinia M.,Chegini S. N. .2018 .A comparison of the effects of Lawsonia inermis (Iranian henna) and clotrimazole on Candida albicans in rats. Journal de Mycologie Médicale, 28(3) : 419-423.
Yang J.,Yang Z.,Yin Y.,Rao M.,Liang Y.,Ge M. .2016 .Three novel polyene macrolides isolated from cultures of Streptomyces lavenduligriseus. The Journal of Antibiotics, 69(1) : 62-65.
Williams D. W.,Lewis M. A. O. .2000 .Oral Microbiology: Isolation and identification of candida from the oral cavity. Oral diseases, 6(1) : 3-11.
Zhang W.,Song X.,Wu H.,Zheng R. .2020 .Epidemiology, species distribution, and predictive factors for mortality of candidemia in adult surgical patients. BMC Infectious Diseases, 20 : 1-11.
0

Citations

0

Downloads

46

Views